Skip to content

McKesson MCK Long-Term Debt

Long-Term Debt at other companies

Eli Lilly logo
Eli LillyLLY
$39.37B+14.1%
Cencora logo
CencoraCOR
$12.18B+71.9%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$2.57B+19.1%
Viatris logo
ViatrisVTRS
$12.41B-12.4%
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
$78.61M+6.4%
Cardinal Health logo
Cardinal HealthCAH

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$104.14B+17.1%
Enterprise value$102.44B+5.1%
P/E21.9×-6.2×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:DebtAndCapitalLeaseObligations.

The official record: McKesson’s 10-Q, filed February 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's long-term debt?
McKesson (MCK) reported long-term debt of $6.6B in Q4 2025.
How has McKesson's long-term debt changed year-over-year?
McKesson's long-term debt increased by 17.9% year-over-year, from $5.6B to $6.6B.
What is the long-term trend for McKesson's long-term debt?
Over 4 years (2021 to 2025), McKesson's long-term debt has grown at a -5.5% compound annual growth rate (CAGR), from $7.15B to $5.7B.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.